Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hersch

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
American Journal of Human Genetics|March 6, 2012
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene regionJong-Min Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, et al.
Human Genetics|July 25, 2012
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Ji-Hyun Lee, et al.
Neurogenetics|May 7, 2013
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Tammy Gillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patientsLuisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, et al.
Neurology|February 11, 2012
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJ-M Lee, E M Ramos, J-H Lee, et al.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
American Journal of Human Genetics|March 6, 2012
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene regionJong-Min Lee, Tammy Gillis, Jayalakshmi Srinidhi Mysore, et al.
Human Genetics|July 25, 2012
Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Ji-Hyun Lee, et al.
Neurogenetics|May 7, 2013
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onsetEliana Marisa Ramos, Jeanne C Latourelle, Tammy Gillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patientsLuisa Quinti, Sharadha Dayalan Naidu, Ulrike Träger, et al.
Neurology|February 11, 2012
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJ-M Lee, E M Ramos, J-H Lee, et al.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 13